News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
NIH Awards Penn State CTSI $28.2M to Improve Rural Health
September 1, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival
August 31, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
N3C Data Validate Two Clinical Tools to Predict COVID-19 Mortality Risk
November 20, 2023 - NCATS News
- National Clinical Cohort Collaborative (N3C)
- Our Impact on Big Data
Two new COVID-19 risk-prediction tools tested in part using the NCATS National COVID Cohort Collaborative (N3C) could help clinicians make faster and better treatment decisions.
Newborn Screening for Rare Immune Disorders Led to Earlier Treatment, Improved Survival
November 20, 2023 - NCATS News
- Rare Diseases Clinical Research Network (RDCRN)
An NCATS-led Rare Diseases Clinical Research Network consortium changed what is known about severe combined immunodeficiency. Researchers developed lifesaving therapies for the disease and pioneered a screening test for newborns.
Is Red Meat Intake Linked to Inflammation?
October 26, 2023 - Media Coverage
- Clinical and Translational Science Awards (CTSA) Program
Can Metformin Treat COVID-19 and Prevent Long COVID? NCATS and Partners Pursue Answers
September 18, 2023 - NCATS News
- COVID-19
NCATS helped researchers explore metformin as a treatment for COVID-19, from early observational studies all the way to the ACTIV-6 clinical trial.
New 3-D Models Offer Insights Into the Biology of a Rare, Devastating Neurological Disease
July 28, 2023 - NCATS News
- 3-D Tissue Bioprinting
- Therapeutics for Rare and Neglected Diseases (TRND)
NCATS scientists created human cell–based models of a rare disorder, NGLY1 deficiency, to learn more about the disease’s development and biology.
Efficient Approach Creates Astrocytes Faster From Stem Cells for Drug Development and Regenerative Medicine
July 24, 2023 - NCATS News
- Our Impact on Drug Discovery and Development
NCATS scientists used stem cells and a novel shortcut to create large supplies of astrocytes to speed research on therapies for neurodegenerative diseases.